UP!

VSAR $1.19

VSAR target price
1.19
0
0

Q reports

Period Date Adjusted Actuals EPS GAAP EPS

Ratings

2016-05-10 Reiterated Rating Canaccord Genuity Buy
2016-04-30 Reiterated Rating Morgan Stanley Hold
2016-04-07 Initiated Coverage Northland Securities Outperform
2016-04-04 Reiterated Rating Canaccord Genuity Buy
2016-02-20 Reiterated Rating Canaccord Genuity Buy
2016-02-19 Lower Price Target Citigroup Inc. $22.00 to $17.00
2016-02-02 Reiterated Rating Canaccord Genuity Buy $28.00
2016-02-02 Reiterated Rating Cowen and Company Buy
2015-12-21 Reiterated Rating Citigroup Inc. Buy $22.00
2015-12-17 Downgrade Credit Suisse Neutral to Underperform $20.00 to $12.00
2015-12-17 Downgrade Credit Suisse Group AG Neutral to Underperform $20.00 to $12.00
2015-11-01 Reiterated Rating Canaccord Genuity Buy $28.00
2015-10-05 Reiterated Rating Canaccord Genuity Buy
2015-09-21 Reiterated Rating Canaccord Genuity Buy
2015-09-15 Reiterated Rating Canaccord Genuity Buy $28.00
2015-08-19 Initiated Coverage Credit Suisse Neutral $20.00
2015-08-13 Initiated Coverage Morgan Stanley Equal to Equal Weight $17.00
2015-08-05 Reiterated Rating Canaccord Genuity Buy $28.00
2015-07-07 Boost Price Target Canaccord Genuity Buy $20.00 to $28.00
2015-05-10 Reiterated Rating SunTrust Buy $50.00 to $45.00
2015-05-10 Reiterated Rating SunTrust Banks Inc. Buy $50.00 to $45.00
2015-05-07 Lower Price Target Canaccord Genuity Buy $45.00 to $20.00
2015-04-13 Initiated Coverage SunTrust Buy $50.00
2015-02-17 Set Price Target Canaccord Genuity Buy $45.00
2014-06-17 Boost Price Target Canaccord Genuity $36.00 to $45.00
2014-04-15 Initiated Coverage Cowen and Company Outperform $45.00
2014-04-15 Initiated Coverage Canaccord Genuity Buy $36.00
2014-04-15 Initiated Coverage Citigroup Inc. Buy $60.00
2014-04-15 Initiated Coverage Morgan Stanley Overweight $79.00
2016-05-10 Reiterated Rating Canaccord Genuity Buy
2016-04-30 Reiterated Rating Morgan Stanley Hold
2016-04-07 Initiated Coverage Northland Securities Outperform
2016-04-04 Reiterated Rating Canaccord Genuity Buy
2016-02-20 Reiterated Rating Canaccord Genuity Buy

There is presents forecasts of rating agencies and recommendations for investors about this ticker

Major Shareholders

Name Relationship Total Shares Holding stocks
New Leaf Ventures II, L.P. 9.96%  (2409374) CMRX / DRTX / MEIP / VSAR /
Advent Life Sciences LLP 9.39%  (2271558) VSAR /
AISLING CAPITAL III LP 8.84%  (2139568) AGRX / DRTX / LOXO / TRXC / TTOO / VSAR /
PERCEPTIVE ADVISORS LLC 8.68%  (2099563) ACRX / AEGR / ALDX / BIOD / FOLD / LJPC / PLCC / RPRX / VSAR / ZGNX /
Shepard Jay President and CEO 2.49%  (602298) DRRX / MRNS / VSAR /
Gut Robert Chief Medical Officer 0.94%  (227300) VSAR /
Westberg Paul Sr. VP, Business Development 0.93%  (225736) VSAR /
Woody Tracy M Chief Commercial Officer 0.89%  (215755) VSAR /
Ward Shane SVP, Legal and Compliance 0.83%  (201556) VSAR /
Brumm Joshua T Chief Financial Officer 0.83%  (201269) VSAR /
Stout Jay S SVP, Technical Operations 0.77%  (185646) VSAR /
Cleland Jeffrey L President and CEO 0.59%  (142396) VSAR /
Haas Kevin VP, Finance and PAO 0.32%  (78218) VSAR /
GREER R SCOTT 0.18%  (44380) ASPX / INGN / NKTR / SIEN / STEM / VSAR /
AKKARAJU SRINIVAS 0.11%  (26155) ICPT / SGEN / VSAR / ZSPH /
Hislop Colin Chief Medical Officer 0.10%  (24500) ANTH / VSAR /
Malik Shahzad 0.10%  (23880) AGEN / CNAT / VSAR /
SUN ANTHONY Y 0.10%  (23880) VSAR /
JENNINGS EDMON R 0.09%  (22380) VSAR /
Varian John 0.09%  (22280) GALE / VSAR / XOMA /
Index Ventures IV (Jersey) LP 0.08%  (19161) VSAR /
DOBMEIER ERIC 0.08%  (18160) ATRA / SGEN / STML / VSAR /